Investment objective & strategy
As of Dec. 1, 2025 · prospectusObjective. The Fund seeks long-term capital appreciation.
Strategy. Principal Investment Strategies: Under normal market conditions, the Fund invests at least 80% of its assets in common stocks of micro capitalization ("micro cap") companies. The Micro Cap Growth Strategy seeks long-term growth of capital by investing primarily in common stocks of growth-oriented domestic issuers which, at the initial time of purchase are within the capitalization range of issuers represented within the Russell Microcap Growth Index. As of the most recent reconstitution date of April 30, 2025, the market capitalization range was $30.3 million to $1.3 billion. RIM's strategy begins by narrowing the microcap stock universe to identify companies that RIM believes have a proven track record of competitive advantages and the ability to produce sustainable value for shareholders in … Principal Investment Strategies: Under normal market conditions, the Fund invests at least 80% of its assets in common stocks of micro capitalization ("micro cap") companies. The Micro Cap Growth Strategy seeks long-term growth of capital by investing primarily in common stocks of growth-oriented domestic issuers which, at the initial time of purchase are within the capitalization range of issuers represented within the Russell Microcap Growth Index. As of the most recent reconstitution date of April 30, 2025, the market capitalization range was $30.3 million to $1.3 billion. RIM's strategy begins by narrowing the microcap stock universe to identify companies that RIM believes have a proven track record of competitive advantages and the ability to produce sustainable value for shareholders in the foreseeable future. From this group, RIM selects securities that it believes are trading at prices below their intrinsic value. RIM sells a stock if it believes the stock is overvalued, more attractive candidates arise, or if there is a substantial, long term reduction in a company's fundamental prospects that impair its value.
Top holdings
As of Jan. 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| PDF SOLUTIONS INC | — | $461.98K | 4.19% |
| LIGAND PHARMACEUTICALS | — | $450.47K | 4.08% |
| PHIBRO ANIMAL HEALTH CORP CL A | — | $407.72K | 3.70% |
| IRADIMED CORP | — | $396.41K | 3.59% |
| ARGAN INC | — | $358.22K | 3.25% |
| DOUGLAS DYNAMICS INC | — | $357.77K | 3.24% |
| METROPOLITAN BANK HOLDING CORP | — | $354.20K | 3.21% |
| BUSINESS FIRST BANCSHARES INC | — | $329.59K | 2.99% |
| UFP TECHNOLOGIES INC | — | $328.99K | 2.98% |
| LEMAITRE VASCULAR INC | — | $308.02K | 2.79% |
Portfolio moves
Oct 31, 2025 → Jan 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Ranger Small Cap Fund · RFTSX, RFISX | 33% | 1.15% |
| Transamerica Small Cap Growth · ASGTX, CSGTX, ISCGX, TSPIX, TSPRX, TSPFX, TSPTX, RTSGX | 31% | 1.00% |
| Acuitas Small Cap Active ETF · AIMS | 27% | 0.75% |
Advisers
| Firm | Role |
|---|---|
| Ranger Investment Management, L.P. | Adviser |
Footnotes
- Expense ratio as of December 1, 2025, from the fund's prospectus.
- Net assets and holdings count as of January 31, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.